Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 122338
Published online Jan 14, 2027. doi: 10.3748/wjg.122338
Published online Jan 14, 2027. doi: 10.3748/wjg.122338
Figure 5 Cumulative incidence function of chemotherapy initiation by bilirubin group.
Cumulative incidence function curves for chemotherapy initiation within 30 days after endoscopic retrograde cholangiopancreatography according to baseline total bilirubin group defined by the 171 μmol/L threshold. Death before chemotherapy initiation was treated as a competing event. The lower panel shows the day-30 cumulative incidence and the number of patients and chemotherapy events in each group. CIF: Cumulative incidence function; sHR: Subdistribution hazard ratio; ERCP: Endoscopic retrograde cholangiopan creatography; TBIL: Total bilirubin.
- Citation: Liao YX, Cao MY, Chen YF, Yang Q, Lin SY, Li Y, Weng J, Huang XX, Gao XY, Wang GB, Li JJ, Shan HB. Early chemotherapy after endoscopic retrograde cholangiopancreatography and survival in advanced pancreatic cancer with biliary obstruction. World J Gastroenterol 2027; 33(2): 122338
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/122338.htm
- DOI: https://dx.doi.org/10.3748/wjg.122338